Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Inhibitors of protein kinases, particularly VEGF-R2 kinase activity, described by GW

Nov. 3, 2000

Recently issued patent covers Pfizer's newest sorbitol dehydrogenase inhibitors

Nov. 2, 2000

Lilly discovers novel polypeptide with potential in obesity Rx

Nov. 2, 2000

New amide inhibitors of cytokine and interleukin production from AstraZeneca

Nov. 2, 2000

Cathepsin inhibitors synthesized at AxyS claimed for osteoporosis, etc.

Nov. 2, 2000

Use of vasopeptidase inhibitors in angina pectoris claimed by BMS

Nov. 2, 2000

Potent, broad-spectrum erythromycin derivatives prepared at Abbott

Nov. 2, 2000

Lanicemine now claimed for treatment of headache

Nov. 2, 2000

Boehringer Ingelheim presents new group of inhibitors of inflammatory cytokines

Oct. 31, 2000

LHRH antagonists particularly useful in hormone-dependent cancer

Oct. 31, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...